Researchers use ‘hot Jupiter’ data to mine exoplanet chemistry

A new Cornell model allows scientists to discern different temperatures on an exoplanet and to better determine a planet’s molecular chemistry.

Astronomy virtual meeting taps Kaltenegger for lecture

Lisa Kaltenegger, associate professor in the astronomy department and director of the Carl Sagan Institute, will give the Fred Kavli Plenary Lecture at the American Astronomical Society virtual meeting.

Mass-produced microscopic sensors see the light

Cornell researchers created low-cost, mass-produced nanoscale sensors that harness light for power and communication.

Chemists create faster-degrading plastic for marine uses

To address the plastic environmental crisis, Cornell chemists have developed a new polymer for a marine setting that is poised to degrade by ultraviolet radiation.

CNF jump-starts startups in New York state

The Cornell NanoScale Science and Technology Facility enables scientists and engineers from academia and industry to conduct micro- and nanoscale research with state-of-the-art technology and expertise from its technical staff. But perhaps the facility’s greatest breakthrough is helping launch startup companies in New York state.

Cornell Atkinson calls for COVID-19 rapid-response proposals

Cornell Atkinson is calling for proposals for faculty research related to the global COVID-19 pandemic. The center’s Rapid Response Fund will award seed grants of up to $10,000 for projects.

Cornell joins global research university climate alliance

Cornell has a long-standing commitment to help lead the fight against climate change, and on April 2 it became a founding member of the International Universities Climate Alliance.

Researchers seek universal treatments to impede coronavirus

New research from a team of Cornell collaborators points to a possible target for antiviral treatment for COVID-19.

Cell-free biotech could drive COVID-19 therapeutics

A biomanufacturing company spun out of Cornell research is seeking to rapidly translate an antibody therapy against COVID-19 by using cell-free biotechnology based on glycoengineered bacteria.